Treatment of hyperkalaemia using intravenous and nebulised salbutamol.
Authors:
- V K PrasadVPV K Prasad
- J T BrocklebankJBJ T Brocklebank
Open Access
- 1 February 1994
- journal article
- research article
- Published by BMJ in Archives of Disease in Childhood
- Vol. 70 (2) , 126-128
Abstract
In 11 children (aged 5-18 years) with end stage chronic renal failure, the effect on plasma potassium of two doses of salbutamol (separated by two hours) given intravenously (4 micrograms/kg) and on a separate date, of salbutamol administered by nebuliser (2.5 mg if the child weighed below 25 kg, 5 mg if above) was observed. Within 30 minutes of the first dose, the mean plasma potassium concentration fell significantly by 0.87 and 0.61 mmol/l after intravenous and nebulised administration respectively. Sixty minutes after the second dose the plasma potassium was significantly reduced by a further 0.28 and 0.53 mmol/l respectively. There was a significant difference between the two methods of administration at 300 minutes after the first dose favouring nebulisation. No major side effects were observed. Nebulised salbutamol should be the first choice emergency treatment of hyperkalaemia.Keywords
This publication has 10 references indexed in Scilit:
- Treatment of hyperkalaemia with intravenous salbutamol.Archives of Disease in Childhood, 1991
- Albuterol and insulin for treatment of hyperkalemia in hemodialysis patientsKidney International, 1990
- Nebulized Albuterol for Acute Hyperkalemia in Patients on HemodialysisAnnals of Internal Medicine, 1989
- Treatment of Hyperkalaemia in Renal Failure: Salbutamol v. InsulinNephrology Dialysis Transplantation, 1989
- Effect of various therapeutic approaches on plasma potassium and major regulating factors in terminal renal failureThe American Journal of Medicine, 1988
- Potassium-lowering effect of albuterol for hyperkalemia in renal failureArchives of internal medicine (1960), 1987
- HYPOKALAEMIA INDUCED BY INHALATION OF FENOTEROLThe Lancet, 1985
- Cardiovascular and biochemical responses to nebulised salbutamol in normal subjects.British Journal of Clinical Pharmacology, 1984
- Adrenergic Modulation of Extrarenal Potassium DisposalNew England Journal of Medicine, 1980
- Metabolic effects of salbutamol: comparison of aerosol and intravenous administration.BMJ, 1977